Browse the evidence

57.8% of plastic surgeons believe GLP-1 agonists are profitable for business.

Many plastic surgeons see GLP-1 agonists as a profitable addition to their practice.

The cancer-preventive effects of obesity pharmacotherapy are less understood.

Further research is needed to clarify the role of obesity pharmacotherapy in cancer prevention.

The integration of digital health and artificial intelligence is expected to advance antiobesity drug development.

Practitioners should consider how digital health tools and AI may enhance treatment strategies for obesity.

Those who reported use of prescription weight loss medication were significantly older and had significantly higher body mass index compared to those who did not report use.

Practitioners should consider age and BMI when assessing patients for prescription weight loss medications.

Eating disorder attitudes and behaviors were more prevalent among boys and men who used prescription weight loss medication.

Practitioners should monitor for eating disorder symptoms in patients using prescription weight loss medications.

Ultra-processed food consumption was higher on weekends compared to weekdays (NOVA Score 3.07 vs. 2.42; p < 0.01).

Practitioners should monitor weekend eating habits in patients post-surgery.

The consumption of fruits and vegetables was lower on weekends.

Encouraging fruit and vegetable intake on weekends may benefit post-surgery patients.

Consumption of hamburgers/sausages, sugar-sweetened beverages, boxed/canned juice, and frozen pizza increased on weekends.

Awareness of increased consumption of unhealthy foods on weekends can guide dietary recommendations.

Understanding the efficacy and potential adverse events of GLP-1 agonists is crucial for therapy initiation.

Both patients and providers should be well-informed before starting GLP-1 agonist therapy.

40.4% of gym users in Sarajevo reported regular food supplement consumption.

Practitioners should be aware that a significant portion of gym users are consuming supplements regularly.

Self-prescription is the predominant method of food supplement use among gym users, with 40.3% reporting this practice.

Practitioners should consider the implications of self-prescription on supplement safety and effectiveness.

Males reported higher food supplement consumption compared to females.

Practitioners should tailor their advice and education on supplements considering gender differences.

43.5% of participants aged 40 and above in Bo District have at least one physiological risk factor for cardiovascular diseases, such as hypertension, obesity, or diabetes.

Health interventions should target older adults to reduce cardiovascular disease risk.

Obesity and type 2 diabetes are considered syndemic.

Recognizing the syndemic nature of obesity and diabetes can inform integrated treatment approaches.

Interest in non-evidence-based practices was greater among women and Black/African American patients.

Healthcare providers should consider demographic factors when discussing weight loss options.

Interest in GLP-1s was associated with lower education and greater social norms.

Understanding educational background may help tailor discussions about GLP-1s.

Past use of non-evidence-based practices was associated with greater pharmaceutical distrust.

Addressing distrust in pharmaceuticals may improve patient engagement with evidence-based treatments.

Current human evidence on the effects of GLP-1 RAs on periodontal health is limited and observational.

Practitioners should be cautious in applying findings from limited human studies to clinical practice.

44.2% of participants consumed between a scoop or two of supplements daily.

This information can guide recommendations for protein supplement intake among gym-goers.

There is a significant relationship between male gender and supplement consumption (OR = 3.055).

Male gym members may be more likely to consume supplements, highlighting a need for targeted education.

40.9% of participants demonstrated high adherence to medication, while 42.6% had low adherence.

Practitioners should be aware that adherence levels are suboptimal in this population.

Key barriers to medication adherence include poor diabetes knowledge, depression, polypharmacy, side effects, inadequate patient-provider communication, and lack of continuity in care.

Addressing these barriers may improve medication adherence.

The prevalence of diagnosed type 2 diabetes mellitus (T2DM) among US adults (≥20 years) is 9.9%, with an average Healthy Eating Index (HEI-2020) score of 53.9.

Healthcare providers should be aware of the prevalence of T2DM and average diet quality in this population.

Males with diagnosed T2DM have a significantly higher HEI score than those without (53.3 vs. 51.8).

Nutrition interventions may need to consider gender differences in dietary quality among those with T2DM.